1. Home
  2. STTK vs EP Comparison

STTK vs EP Comparison

Compare STTK & EP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$3.95

Market Cap

275.9M

Sector

Health Care

ML Signal

HOLD

Logo Empire Petroleum Corporation

EP

Empire Petroleum Corporation

HOLD

Current Price

$3.38

Market Cap

113.3M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
STTK
EP
Founded
2016
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
275.9M
113.3M
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
STTK
EP
Price
$3.95
$3.38
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$6.20
N/A
AVG Volume (30 Days)
319.7K
39.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
27.32
1.82
EPS
N/A
N/A
Revenue
$5,721,000.00
$43,650,292.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
245.26
8.92
52 Week Low
$0.69
$2.77
52 Week High
$4.89
$6.90

Technical Indicators

Market Signals
Indicator
STTK
EP
Relative Strength Index (RSI) 46.85 60.09
Support Level $3.52 $2.81
Resistance Level $4.23 $3.47
Average True Range (ATR) 0.28 0.23
MACD -0.02 0.04
Stochastic Oscillator 23.85 50.00

Price Performance

Historical Comparison
STTK
EP

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About EP Empire Petroleum Corporation

Empire Petroleum Corp is a conventional oil and natural gas producer with a main focus in the United States onshore. The company possesses long-life, mature, producing assets with slow decline profiles in the Permian Basin, Bakken region and central Gulf Coast region, in the states of New Mexico, North Dakota, Montana, Louisiana and Texas. It has production from operated and non-operated wells in Lea County in New Mexico, Bottineau, Renville, Burke, and McKenzie Counties in North Dakota, Richland County in Montana, St. Landry, Beauregard Parishes in Louisiana and Houston, Leon and Madison Counties in Texas.

Share on Social Networks: